HAURAKI PHO
  • Home
  • About us
    • Our People
  • Services We Offer
    • HPHO Practices
    • After Hours Services
    • Breast and Cervical Screening Support
    • Diabetes Management
    • Heart Check
    • Ngā Kaitiaki Manawanui Whai Ora
    • Outreach Immunisation Service
    • Primary Options
    • Patient Portal
    • Primary Mental Health Services
    • Shared Electronic Health Record
  • News & Support
    • Education and Training
    • Coronavirus Updates >
      • COVID-19 Vaccine Updates
    • Join the Team!
  • Hauraki Locality
  • Contact
  • Home
  • About us
    • Our People
  • Services We Offer
    • HPHO Practices
    • After Hours Services
    • Breast and Cervical Screening Support
    • Diabetes Management
    • Heart Check
    • Ngā Kaitiaki Manawanui Whai Ora
    • Outreach Immunisation Service
    • Primary Options
    • Patient Portal
    • Primary Mental Health Services
    • Shared Electronic Health Record
  • News & Support
    • Education and Training
    • Coronavirus Updates >
      • COVID-19 Vaccine Updates
    • Join the Team!
  • Hauraki Locality
  • Contact

SHORT SUPPLY OF FLUOXETINE AND SERTRALINE 26-3-20

27/3/2020

 
I understand that in some areas there is short/no supply of fluoxetine and sertraline This appears to be related to supply chains as opposed to the country running out of these medications. Some pharmacies appear to have run out of these medications; others continue to have some supplies. I understand that other SSRIs (citalopram and escitalopram) are still available.
CONTINUED...
If ongoing antidepressant treatment is required and your patient is unable to obtain supplies of their fluoxetine or sertraline, I would recommend changing to another SSRI (citalopram, escitalopram, paroxetine), or a different class of antidepressant such as venlafaxine or mirtazapine especially if they did not adequately respond to an adequate trial of fluoxetine or sertraline.
When switching medications (especially from fluoxetine), please be aware of the impact on Cytochrome P450 metabolism of other medications (e.g. warfarin) that in turn may require further monitoring and dose adjustments.
Please also closely monitor for any variations in mood, anxiety, agitation and suicidal ideation during the change over period.
I would recommend switching according to the NZF Antidepressant Switching Table: https://nzf.org.nz/nzf/resource/Antidepressant_Switching_Table.pdf.

When switching from one serotonergic agent to another, there is a very low risk of inducing serotonergic syndrome. This link provides a good summation of clinical signs and symptoms: https://www.medsafe.govt.nz/profs/PUArticles/SerotoninSyndromeToxicityReminder.htm
This patient brochure is available at: https://www.medsafe.govt.nz/consumers/educational-material/Serotonin%20Syndrome%20December%202015.pdf
Please do not hesitate to contact me should you have any questions.
Click here for printable document
Dr Andrew Darby
Primary Care Consultant Psychiatrist

Comments are closed.

    Author

    Write something about yourself. No need to be fancy, just an overview.

    Archives

    October 2022
    August 2022
    July 2022
    March 2022
    February 2022
    December 2021
    November 2021
    October 2021
    September 2021
    August 2021
    July 2021
    June 2021
    May 2021
    April 2021
    March 2021
    February 2021
    January 2021
    December 2020
    November 2020
    October 2020
    September 2020
    August 2020
    July 2020
    June 2020
    May 2020
    April 2020
    March 2020
    February 2020
    January 2020

    Categories

    All

    RSS Feed

THAMES
106 Sealey Street, Thames 3500
phone 07-868-9686
Send us a message
HAMILTON
​16 Patikitiki​ Street, Hamilton East
​Hamilton 3216

phone 07-868-9686
Send us a message
Picture
Copyright © Hauraki Primary Health Organisation  |  2020